Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
05/2005
05/12/2005US20050101760 reacting polyhydroxypropionate isolated from plant biomass with ammonia to form alkenoic amide (acrylamide, methacrylamide); depolymerization
05/12/2005US20050101671 Compounds and compositions for delivering active agents
05/12/2005US20050101661 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents
05/12/2005US20050101645 P-(alpha-hydroxyhydrocarbylcarbonylamino)-substituted benzoic acid esters; reducing and/or slowing down the loss of head hair and/or body hair, or inducing and/or stimulating its growth
05/12/2005US20050101644 Benzylether amine compounds useful as CCR-5 antagonists
05/12/2005CA2543756A1 Hydroxypropyl amides for the treatment of alzheimer's disease
05/12/2005CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005CA2535036A1 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/11/2005EP1257526B1 Aniline-derived ligands for the thyroid receptor
05/11/2005EP1100771B1 Compounds and compositions for delivering active agents
05/11/2005EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
05/11/2005CN1615295A Compounds for treatment of inflammation, diabetes and related disorders
05/11/2005CN1613846A Synthesis of water soluble oxamonoamide
05/11/2005CN1200945C Process for acylation of amino alcohols
05/10/2005US6891072 Process for production of dimers or aromatic monohydroxyl compounds
05/10/2005US6890932 Anthranilic acid derivative
05/10/2005CA2296450C Polyalkanolamide tackifying resins for creping adhesives
05/06/2005WO2005040103A1 Medicinal compounds
05/06/2005WO2005040100A1 Tetrahydro-naphthalene and urea derivatives
05/06/2005WO2005040094A1 Novel dendrimer compound and a biochip using the same
05/06/2005WO2004031107A8 Method for the production of at least one partial propylene oxidation and/or ammoxidation product
05/06/2005CA2542494A1 Tetrahydro-naphthalene and urea derivatives
05/05/2005US20050096485 Thyronamine derivatives and analogs and methods of use thereof
05/05/2005US20050096328 Certain 1-(D-cycloproplyglycinyl)-4-piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa
05/04/2005CN1612857A Geranyl compounds
05/04/2005CN1612852A Lipoxin A4 analogs
05/03/2005US6887877 Viricide for hepatitis virus
05/03/2005US6887866 Short-acting sedative hypnotic agents for anesthesia and sedation
05/03/2005CA2133337C Compounds useful for treating allergic or inflammatory diseases
05/03/2005CA2114114C Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors
04/2005
04/28/2005WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
04/28/2005WO2005037206A2 Anti-cancer compounds and methods of use thereof
04/28/2005WO2005037205A2 Haloacetamide and azide substituted compounds and methods of use thereof
04/28/2005WO2005014517A3 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
04/28/2005WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation
04/28/2005US20050090555 Compound for the treatment of metabolic disorders
04/28/2005US20050090546 Compounds such as N,N-dibenzylphenylalanine benzyl ester, used as enzyme inhibitors; prophylaxis of lymphadenopathy associated virus, cancer and malaria
04/28/2005CA2542807A1 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
04/27/2005EP1526128A2 Process the preparation of alpha-hydroxycarboxylic acid amides
04/27/2005EP1525186A1 Inhibitors of hcv ns5b polymerase
04/27/2005EP1525185A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease
04/27/2005EP1525183A1 Inhibitors of hcv ns5b polymerase
04/27/2005CN1610659A Carboxylic acid derivative
04/27/2005CN1610657A Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3, 5-dihydroxy heptanoic acid derivatives, and intermediates thereof
04/26/2005US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent
04/26/2005US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders
04/26/2005CA2053253C New aryl-and heteroarylethenylene derivatives and process for their preparation
04/21/2005WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/21/2005WO2005035497A1 Caspase inhibitor comprising 2-alkyl-4-oxobutanoyl group and pharmaceutical composition thereof
04/21/2005US20050085544 Alkylation a cyanoester with dibromopropane; cyclization
04/21/2005US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
04/21/2005US20050085449 Antidepressants; sexual disorders; osteoporosis; alopecia; anemia; benign prostate hyperplasia; anticancer agents
04/21/2005US20050084506 Amide compounds such as (R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate and urea compounds such as 1-(2-chlorophenyl)-3-(heptan-4-yl)urea for modulating taste of food or drug products
04/21/2005CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/20/2005EP1524262A1 Inhibitors of histone deacetylase
04/20/2005EP1523469A1 Cinnamide derivatives
04/20/2005EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors
04/20/2005EP1165495B1 Resorcinol derivatives
04/20/2005EP1089968B1 Thyroid hormone analogues and methods for their preparation
04/20/2005CN1608055A Compounds for the treatment of metabolic disorders
04/19/2005US6881846 Antiproliferative agents
04/19/2005US6881845 Reacting p-fluoroacetophenone with formaldehyde and methylbenzylamine, then hydrogenation, cyclization and reducing to form chemical intermediates for paroxetine and omiloxetine
04/19/2005US6881754 Adamantane derivatives
04/19/2005CA2333199C Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof
04/14/2005WO2005033255A1 Detergent compositions and processes for the production thereof
04/14/2005WO2005033180A1 Aspartate derivatives and process for their preparation
04/14/2005WO2005033059A1 Compounds for the treatment of diseases associated with the formation of amyloid fibrils
04/14/2005US20050080135 Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and/or benzamidoalkylamines
04/14/2005US20050080119 Diaminopropionic acid derivatives
04/14/2005US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
04/14/2005CA2540660A1 Aspartate derivatives and process for their preparation
04/13/2005EP1522304A2 Compositions containing avenanthramides from extract of oats
04/13/2005EP1521733A1 Modulators of the glucocorticoid receptor
04/13/2005CN1196673C (-)-Verbenzone derivs.
04/07/2005WO2005030705A1 Inhibitors of histone deacetylase
04/07/2005WO2005030704A1 Inhibitors of histone deacetylase
04/07/2005WO2005030702A1 Biphenyloxy-acids
04/07/2005WO2005014533A3 Aryl and heteroaryl compounds, compositions, and methods of use
04/07/2005US20050075476 Process for preparing aspartates
04/07/2005US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals
04/07/2005US20050075368 Solvent extracting natural E2,E4-decadienal and undecadienal from ground, dried fruit of piper species; oxidation, esterification and transamidation; taste and aroma enhancers; bactercidel, fungicide and insecticidide activity
04/07/2005US20050075367 Ester compound and medicinal use thereof
04/07/2005CA2539250A1 Biphenyloxy-acids
04/07/2005CA2539117A1 Inhibitors of histone deacetylase
04/06/2005EP1520850A2 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
04/06/2005EP1520030A1 Microorganisms and processes for enhanced production of pantothenate
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/06/2005EP0973726B1 Method for synthesis of rhizoferrin
04/06/2005CN1603291A Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
04/05/2005CA1341478C Therapeutic methods using catalytic antibodies
03/2005
03/31/2005WO2005028463A1 Cinnamoyl compound and use of the same
03/31/2005WO2005028439A1 Cinnamoyl compound and use of the same
03/31/2005WO2005016867A3 Anthranilic acid derivatives and their use as activators of the hm74a receptor
03/31/2005WO2004113270A3 Propionic acid derivatives useful in the treatment of lipid disorders
03/31/2005US20050070485 Phenylalanine derivatives
03/31/2005CA2539165A1 Cinnamoyl compound and use of the same
03/31/2005CA2538960A1 Cinnamoyl compound and use of the same
03/30/2005EP1517975A2 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
03/30/2005EP1517883A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
03/30/2005EP1517882A1 Amide linker peroxisome proliferator activated receptor modulators
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 157